SATB2 Is Expressed in a Subset of Pulmonary and Thymic Neuroendocrine Tumors.
Julie A VranaJennifer M BolandSimone B S P TerraHao XieSarah M JenkinsAaron S MansfieldJulian R MolinaStephen D CassiviAnja C RodenPublished in: American journal of clinical pathology (2021)
SATB2 (clone EP281) is expressed in a large subset of pulmonary and thymic neuroendocrine tumors and therefore does not appear to be a useful marker to identify the origin of neuroendocrine tumors. Validation studies are needed, specifically including thymic neuroendocrine tumors, as the expression pattern might be different in those tumors.